Crystallization of three key glycolytic enzymes of the opportunistic pathogen Cryptosporidium parvum

Tzipori, 1998, Natural history and biology of Cryptosporidium parvum, Adv. Parasitol., 40, 5, 10.1016/S0065-308X(08)60116-5 Mosier, 2001, Cryptosporidiosis. A global challenge, Ann. N. Y. Acad. Sci., 916, 102, 10.1111/j.1749-6632.2000.tb05279.x Okhuyesen, 2002, Cryptosporidium virulence determinants—Are we there yet?, Int. J. Parasitol., 32, 517, 10.1016/S0020-7519(01)00356-3 Clark, 1999, New insights into human cryptosporidiosis, Clin. Microbiol. Rev., 12, 554, 10.1128/CMR.12.4.554 Nannini, 2002, HIV1 and the gut in the era of highly active antiretroviral therapy, Curr. Gastroenterol. Rep., 4, 392, 10.1007/s11894-002-0009-z Tzipori, 2002, Cryptosporidiosis: biology, pathogenesis and disease, Microb. Infect., 4, 1047, 10.1016/S1286-4579(02)01629-5 Dillingham, 2002, Cryptosporidiosis: epidemiology and impact, Microb. Infect., 4, 1059, 10.1016/S1286-4579(02)01630-1 Coombs, 1999, Biochemical peculiarities and drug targets in Cryptosporidium parvum: lessons from other Coccidian parasites, Parasitol. Today, 15, 333, 10.1016/S0169-4758(99)01474-X Carey, 2004, Biology, persistence and detection of Cryptosporidium parvum and Cryptosporidium hominis oocyst, Water Res., 38, 818, 10.1016/j.watres.2003.10.012 Denton, 1996, Comparison of the phosphofructokinase and pyruvate kinase activities of Cryptosporidium parvum, Eimeria tenella and Toxoplasma gondii, Mol. Biochem. Parasitol., 76, 23, 10.1016/0166-6851(95)02527-8 Entrala, 1997, Glycolytic enzyme activities in Cryptosporidium parvum oocysts, FEMS Microbiol. Lett., 151, 51, 10.1111/j.1574-6968.1997.tb10393.x Abrahamsen, 2004, Complete genome sequence of the apicomplexan, Cryptosporidium parvum, Science, 304, 441, 10.1126/science.1094786 Callens, 1995, The rational design of trypanocidal drugs: selective inhibition of the glyceraldehyde-3-phosphate dehydrogenase in Trypanosomatidae, Ann. Trop. Med. Parasitol., 89, 23, 10.1080/00034983.1995.11813011 Bressi, 2001, Adenosine analogues as selective inhibitors of glyceraldehyde-3-phosphate dehydrogenase of Trypanosomatidae via structure-based drug design, J. Med. Chem., 44, 2080, 10.1021/jm000472o Lakhdar-Ghazal, 2002, Glycolysis and proteases as targets for the design of new anti-trypanosome drugs, Curr. Top. Med. Chem., 2, 439, 10.2174/1568026024607472 Mattevi, 1996, The allosteric regulation of pyruvate kinase, FEBS Lett., 389, 15, 10.1016/0014-5793(96)00462-0 Rigden, 1999, The structure of pyruvate kinase from Leishmania mexicana reveals details of the allosteric transition and unusual effector specificity, J. Mol. Biol., 291, 615, 10.1006/jmbi.1999.2918 Dunn, 1996, The structure of lactate dehydrogenase from Plasmodium falciparum reveals a new target for anti-malarial design, Nat. Struct. Biol., 3, 912, 10.1038/nsb1196-912 Royer, 1986, Biologically active derivatives of gossypol: synthesis and antimalarial activities of peri-acylated gossylic nitriles, J. Med. Chem., 29, 1799, 10.1021/jm00159a043 Madern, 2004, Evolution of Cryptosporidium parvum lactate dehydrogenase from malate dehydrogenase by a very recent event of gene duplication, Mol. Biol. Evol., 21, 489, 10.1093/molbev/msh042 Dando, 2001, The kinetic properties and sensitivities to inhibitors of lactate dehydrogenases (LDH1 and LDH2) from Toxoplasma gondii: comparisons with pLDH from Plasmodium falciparum, Mol. Biochem. Parasitol., 118, 23, 10.1016/S0166-6851(01)00360-7 Gomez, 1997, Substrate and cofactor specificity and selective inhibition of lactate dehydrogenase from the malarial parasite P. falciparum, Mol. Biochem. Parasitol., 90, 235, 10.1016/S0166-6851(97)00140-0 Zhu, 2002, Alpha-proteobacterial relationship of apicomplexan lactate and malate dehydrogenases, J. Eukaryot. Microbiol., 49, 255, 10.1111/j.1550-7408.2002.tb00532.x Bankier, 2003, Integrated mapping, chromosomal sequencing and sequence analysis of Cryptosporidium parvum, Genome Res., 13, 1787, 10.1101/gr.1555203 Otwinoski, 1997, Processing of X-ray diffraction data collected in oscillation mode, Methods Enzymol., 276, 307, 10.1016/S0076-6879(97)76066-X Etges, 1988, Purification and characterization of a metabolite-regulated pyruvate kinase from Leishmania major promastigotes, Mol. Biochem. Parasitol., 27, 281, 10.1016/0166-6851(88)90048-5 Wooll, 2001, Structural and functional linkages between subunit interfaces in mammalian pyruvate kinase, J. Mol. Biol., 312, 525, 10.1006/jmbi.2001.4978 Matthews, 1968, Solvent content of protein crystal, J. Mol. Biol., 33, 494, 10.1016/0022-2836(68)90205-2 Kuntz, 1992, Structure-based strategies for drug design and discovery, Science, 257, 1078, 10.1126/science.257.5073.1078